Cargando…
Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
BACKGROUND: Phenylketonuria (PKU) is a rare genetic metabolic disorder in which especially high phenylalanine (Phe) concentrations cause brain dysfunction. If untreated, this brain dysfunction results in severe microcephaly, intellectual disability, and behavioral problems. Dietary restriction of Ph...
Autores principales: | Maler, Victor, Goetz, Violette, Tardieu, Marine, Khalil, Abderrahmane El, Alili, Jean Meidi, Meunier, Philippe, Maillot, François, Labarthe, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249154/ https://www.ncbi.nlm.nih.gov/pubmed/37291632 http://dx.doi.org/10.1186/s13023-023-02770-x |
Ejemplares similares
-
Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences
por: Newbould, Ella, et al.
Publicado: (2021) -
Aspartame Not Linked to Cancer
por: Abegaz, Eyassu G.
Publicado: (2007) -
Aspartame: Soffritti Responds
por: Soffritti, Morando
Publicado: (2007) -
Development of an HPLC Method with an ODS Column to Determine Low Levels of Aspartame Diastereomers in Aspartame
por: Ohtsuki, Takashi, et al.
Publicado: (2016) -
Carcinogenicity of Aspartame in Rats Not Proven
por: Magnuson, Bernadene, et al.
Publicado: (2008)